Online citations, reference lists, and bibliographies.

A Meta-analysis Of The Effects Of Antidepressants On Cognitive Functioning In Depressed And Non-depressed Samples

Catherine E. Prado, Stéphanie Watt, Simon F. Crowe
Published 2018 · Medicine, Psychology
Cite This
Download PDF
Analyze on Scholarcy
Share
A thorough understanding of the cognitive effects of antidepressant medications is essential given their frequency of use. This meta-analysis was conducted to investigate whether antidepressants differentially affect the various domains of cognitive functioning for depressed and non-depressed participants. An electronic search of PsycInfo, Medline and Google Scholar was conducted for all journal articles published between January 1998 and January 2017. Thirty-three studies were included enabling calculation of Hedges’ g using a random effects model for the cognitive domains of divided attention, executive function, expressive language, immediate memory, perceptual motor skills, processing speed, recent memory, sustained attention, visuospatial-constructional skills and working memory. Results revealed that overall, antidepressants have a modest, positive effect on divided attention, executive function, immediate memory, processing speed, recent memory and sustained attention for depressed participants. Selective serotonin reuptake inhibitors (SSRI’s) were found to have the greatest positive effect on cognition for depressed participants, as compared to the other classes of antidepressants analysed. Antidepressants did not significantly affect cognitive function in non-depressed participants.
This paper references
10.1097/01.jcp.0000227699.26375.f8
Mood and neuropsychological changes in women with midlife depression treated with escitalopram.
Tonita E. Wroolie (2006)
10.1037/a0025594
Effects of varenicline and bupropion on cognitive processes among nicotine-deprived smokers.
Rebecca L. Ashare (2012)
10.1016/S0165-0327(99)00092-0
Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
Ian Muir Anderson (2000)
10.1017/s0033291798008010
Anxiety, depression, psychotropic drug use and cognitive impairment.
Sabrina Paterniti (1999)
10.1097/00019442-199908000-00006
Comparative efficacy of sertraline vs. fluoxetine in patients age 70 or over with major depression.
Sanford I. Finkel (1999)
10.1016/j.pharmthera.2012.09.006
Serotonin receptors involved in antidepressant effects.
Francesc Pardo i Artigas (2013)
10.1076/clin.12.1.43.1726
Hopkins Verbal Learning Test - Revised: Normative Data and Analysis of Inter-Form and Test-Retest Reliability*
Ralph H. B. Benedict (1998)
10.1007/978-1-4614-5269-0_8
Measures of Expressive Language
Donna A. Morere (2012)
10.1097/jcp.0b013e31814b98c1
Does serotonin augmentation have any effect on cognition and activities of daily living in Alzheimer's dementia? A double-blind, placebo-controlled clinical trial.
Arash Mowla (2007)
10.1016/S0165-0327(98)00222-5
Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion.
W. Dale Horst (1998)
Pharmacological and non
B. T. Baune (2014)
Mediators of the association
E. Sonderen (2008)
10.1093/brain/awf049
Decision-making processes following damage to the prefrontal cortex.
Facundo Manes (2002)
10.1517/14740338.2.4.367
Safety of antidepressants in the elderly
Barbara R. Sommer (2003)
10.2174/0929867043364810
Monoamine oxidases: certainties and uncertainties.
Keith F. Tipton (2004)
10.1097/00019442-200401000-00007
Longitudinal association of initiation/perseveration and severity of geriatric depression.
Christopher F. Murphy (2004)
10.1186/s12874-016-0136-0
Meta-analyses including non-randomized studies of therapeutic interventions: a methodological review
Timor Faber (2016)
10.1176/appi.ajp.157.12.1949
Changes in cognitive functioning following treatment of late-life depression.
Meryl A. Butters (2000)
10.1001/archgenpsychiatry.2009.81
National patterns in antidepressant medication treatment.
Mark Olfson (2009)
10.1212/WNL.24.11.1019
Evaluating storage, retention, and retrieval in disordered memory and learning
Herman Buschke (1974)
10.1090/fim/023/04
早期関節リウマチ:brief overview
寛 大岩 (2018)
10.1016/S0140-6736(05)63832-9
Meta-analysis of randomised controlled trials
Peter M. Rothwell (1997)
10.1002/14651858.CD003012.pub2
Active placebos versus antidepressants for depression.
Joanna Moncrieff (2004)
10.1192/bjp.bp.108.051193
Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action.
Catherine J. Harmer (2009)
10.1001/archgenpsychiatry.2009.185
Escitalopram and enhancement of cognitive recovery following stroke.
Ricardo E Jorge (2010)
10.2190/KQ48-XT0L-2H14-5UMV
Fluoxetine's Effects on Cognitive Performance in Patients with Traumatic Brain Injury
Stefanie A Horsfield (2002)
10.4103/0019-5545.74318
How antidepressant drugs act: A primer on neuroplasticity as the eventual mediator of antidepressant efficacy
Chittaranjan Andrade (2010)
10.1016/S0140-6736(97)08468-7
Summing up evidence: one answer is not always enough
Joseph Lau (1998)
10.1093/gerona/58.12.M1137
Does antidepressant therapy improve cognition in elderly depressed patients?
P. Murali Doraiswamy (2003)
10.1016/j.psychres.2010.03.006
Effects of selective serotonin reuptake and dual serotonergic–noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder
Ixchel Herrera-Guzmán (2010)
10.1017/S0033291713002535
Cognitive impairment in depression: a systematic review and meta-analysis.
Philippa L Rock (2014)
10.1023/B:NERV.0000009483.91468.fb
The Ecological Validity of Neuropsychological Tests: A Review of the Literature on Everyday Cognitive Skills
Naomi S Chaytor (2004)
Impaired extra-dimensional shift
T. W. Robbins (1989)
10.2165/00002512-199405030-00005
Effects of Antidepressants on Cognitive Functioning of Elderly Patients
Henderikus Knegtering (1994)
10.1016/j.psychres.2014.05.013
Pharmacological and non-pharmacological interventions to improve cognitive dysfunction and functional ability in clinical depression – A systematic review
Bernhard T. Baune (2014)
Fluoxetine's effects on
J. Mastropaolo (2002)
Antidepressive agents and memory
Danion Jm (1993)
10.1002/9781118660584.ese0399
California Verbal Learning Test, Second Edition
Ron Dumont (2014)
Cognitive deficits are associated
W. V. McCall (2003)
10.1016/j.cpr.2010.03.006
A meta-analysis of the effects of psychotherapy with sexually abused children and adolescents.
Shane T Harvey (2010)
10.1126/science.1083328
Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants
Luca Santarelli (2003)
10.1016/j.neuropharm.2012.06.064
Modafinil, but not escitalopram, improves working memory and sustained attention in long-term, high-dose cocaine users
Ari D. Kalechstein (2013)
10.1002/da.22063
Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions.
Roger S. McIntyre (2013)
Does fluoxetine
A. Mowla (2007)
The Category Specific Names Test. Levittown
P. McKenna (1998)
10.1016/S0006-3223(02)01674-8
Working memory and prefrontal cortex dysfunction: specificity to schizophrenia compared with major depression
Deanna M. Barch (2003)
10.4135/9781412950589.n265
Ecological Validity
Martyn Shuttleworth (2019)
Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson ' s disease and concurrent depression
M. Borenstein (2005)
10.1093/aje/kwp016
Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles.
Ian Shrier (2007)
10.1146/annurev.neuro.22.1.197
Monoamine oxidase: from genes to behavior.
Jean C Shih (1999)
10.1186/1471-244X-7-32
Disability in major depression related to self-rated and objectively-measured cognitive deficits: a preliminary study
Sharon L Naismith (2007)
Evaluation of storage , retention and retrieval in disordered memory and learning
M. A. Butters (1974)
Active placebos versus
J. Moncrieff (2004)
10.1093/acrefore/9780199975839.013.104
Diagnostic and Statistical Manual of Mental Disorders
Janet B. W. Williams (2013)
10.1192/bjp.182.3.214
Neurocognitive impairment in drug-free patients with major depressive disorder.
Richard J Porter (2003)
10.1017/s0033291799001968
Decreased working memory and processing speed mediate cognitive impairment in geriatric depression.
Robert D. Nebes (2000)
10.1097/YIC.0b013e3283542457
A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder.
Cornelius Katona (2012)
10.1002/pds.1385
Reasons for antidepressant prescriptions in Canada.
Scott B. Patten (2007)
10.1017/S0033291703007682
Neuropsychological performance of OCD patients before and after treatment with fluoxetine: evidence for persistent cognitive deficits.
Marjan M. A. Nielen (2003)
from COMPENDIUM 肺葉捻転
John C. Gicking (2010)
Changes in cognitive
B. G. Pollock (2000)
10.1177/026988110001400101
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines
Ian Muir Anderson (2000)
10.2165/00002018-199614040-00002
Monoamine Oxidase Inhibitors
Martin G. Livingston (1996)
10.1076/jcen.23.1.121.1223
The Role of Functional Neuroimaging in the Neuropsychology of Depression
Mario Liotti (2001)
10.1016/S0006-3223(00)00910-0
Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery
John A. Sweeney (2000)
10.7326/0003-4819-132-9-200005020-00011
A Systematic Review of Newer Pharmacotherapies for Depression in Adults: Evidence Report Summary: Clinical Guideline, Part 2
John W. Williams (2000)
Pattern of impaired working memory
E. S0033291713002535. Rose (2006)
10.1177/026988110201600303
Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man
Jeroen A. J. Schmitt (2002)
10.1155/2014/627863
Does Duloxetine Improve Cognitive Function Independently of Its Antidepressant Effect in Patients with Major Depressive Disorder and Subjective Reports of Cognitive Dysfunction?
Tracy L. Greer (2014)
Evidence of absence: A guide to cognitive assessment in Australia
S. Crowe (2010)
10.1037//0894-4105.9.2.255
Speech and language in high-functioning autistic individuals.
Nancy J. Minshew (1995)
10.1037/t15149-000
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
Jr. Christopher S. Randolph (2009)
10.1017/S1461145714000546
A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults
Roger S. McIntyre (2014)
10.1007/s10202-008-0060-4
Antidepressants for neuroenhancement in healthy individuals: a systematic review
Dimitris Repantis (2009)
10.1371/journal.pmed.0050045
Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration
Irving Kirsch (2008)
Pathways linking late-life depression to persistent cognitive impairment and dementia
Meryl A. Butters (2008)
10.1136/bmj.326.7397.1014
Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis
Steve Macgillivray (2003)
10.2307/2529115
Statistical Power Analysis for the Behavioral Sciences
Jacob Cohen (1969)
10.2478/v10039-010-0053-0
Auditory-verbal declarative and operating memory among patients suffering from depressive disorders - preliminary study.
Monika Talarowska (2010)
10.3949/ccjm.73.4.351
Side effects of antidepressants: an overview.
Elias A. Khawam (2006)
The unity and diversity of executive
T. D. Wager (2000)
10.1097/01.psyphr.0000422136.00732.93
Monoamine oxidase inhibitors.
M J Dent (1970)
Executive functions and updating of the contents
(2004)
10.1111/j.1399-5618.2008.00639.x
Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression.
Seyyed Nassir Ghaemi (2008)
10.1016/S0887-6177(96)00003-0
Subscale validity of the Mattis Dementia Rating Scale.
Daniel C. Marson (1997)
10.1002/hup.668
Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury.
H J Lee (2005)
10.1016/S0301-0511(00)00052-1
Aging and measures of processing speed
Timothy Salthouse (2000)
10.1002/mds.20508
Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson's disease and concurrent depression.
Paulo S. Boggio (2005)
Decision-making processes following damage
T. Robbins (2002)
A meta-analysis of depres
L. M. McDermott (2009)
RBANS Manual: Repeatable battery for the assess
technical (1998)
10.1037/a0028141
Parsing trait and state effects of depression severity on neurocognition: Evidence from a 26-year longitudinal study.
Casey Sarapas (2012)
10.1037/0882-7974.19.1.211
Adult age and digit symbol substitution performance: a meta-analysis.
William J. Hoyer (2004)
Diagnostic and Statistical Manual of Mental Disorders, 5th ed.
Marcia Jean Carter (2014)
10.1097/HTR.0b013e3181d6c715
Impact of early administration of sertraline on cognitive and behavioral recovery in the first year after moderate to severe traumatic brain injury.
James H. Baños (2010)
Mechanisms of action and clin
S. H. Preskorn (1998)
10.1177/2045125312445469
The drugs don’t work? antidepressants and the current and future pharmacological management of depression
Elizabeth Maggie Penn (2012)
10.1002/sim.5766
Interpreting meta-regression: application to recent controversies in antidepressants' efficacy.
Eva Petkova (2013)
10.1016/j.biopsych.2004.04.002
Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment
Meena Vythilingam (2004)
Conner’s Continuous Performance Test (CPT II) computer programs for Windows: Technical manual and software guide (Ver
C. K. Conners (2000)
10.1146/annurev-clinpsy-032814-112828
Depression and cognition in the elderly.
Sophia Wang (2015)
10.1016/0895-4356(92)90054-Q
Variance imputation for overviews of clinical trials with continuous response.
Dean A Follmann (1992)
10.4088/JCP.13r08609
Cognitive effects of pharmacotherapy for major depressive disorder: a systematic review.
Richard S. E. Keefe (2014)
Antidepressants and cognitive impairment in the elderly.
Thomas E. Oxman (1996)
10.1177/0269881116681399
Low doses of mirtazapine or quetiapine for transient insomnia: A randomised, double-blind, cross-over, placebo-controlled trial
Julie Karsten (2017)
A meta-analysis of effects of
Phillip Allan Lancaster (2014)
10.1192/bjp.178.3.200
Cognitive deficits in depression: possible implications for functional neuropathology.
Marie-Paule Austin (2001)
10.1517/14728210903107751
Emerging drugs for major depressive disorder
Sidney H. Kennedy (2009)
Change In Cognitive Functioning Following Acute Antidepressant Treatment In Late-Life Depression
Michelle E Reinlieb (2013)
10.1016/S0006-3223(03)00231-2
Diagnosis and definition of treatment-resistant depression
Maurizio Fava (2003)
10.1586/14737175.2.6.849
SNRIs: mechanism of action and clinical features
Olivier Lambert (2002)
10.1136/bmj.327.7414.557
Measuring inconsistency in meta-analyses
Julian P. T. Higgins (2003)
10.1007/s00213-003-1686-5
Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial
Julia B. Deakin (2003)
Rey Auditory-Verbal Learning Test
M. N. Mitruchina (1999)
10.1001/archpsyc.64.5.532
Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia.
Dwight Dickinson (2007)
Cognitive deficits
L. A. Gallaugher (2013)
10.1017/S0033291703008559
Cognitive functions in depressive disorders: evidence from a population-based study.
Eija Airaksinen (2004)
10.3109/09638289509166638
The Purdue Pegboard Test: normative data for people aged 60 and over.
Johanne Desrosiers (1995)
10.1016/j.neuroimage.2009.09.008
Functional neural correlates of fluid and crystallized analogizing
John G. Geake (2010)
10.1136/bmj.b3128
Disagreements in meta-analyses using outcomes measured on continuous or rating scales: observer agreement study
Britta Tendal (2009)
10.1177/026988119701100204
Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression
Guy M. Goodwin (1997)
10.1056/JP199802010000003
Cognitive Deficits in Depression and Alzheimer's Disease
G Tucker (1998)
Sertraline treatment of elderly
Y. Stern (2003)
Auditory-verbal declarative and operating
P. Gałecki (2010)
10.1136/bmj.326.7379.1
Breast self examination
Joan Austoker (2003)
10.1038/npp.2015.52
A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder
Atul R. Mahableshwarkar (2015)
10.1016/j.acn.2003.09.009
Speed and memory in the WAIS-III Digit Symbol--Coding subtest across the adult lifespan.
Stephen W. Joy (2004)
10.1212/WNL.0000000000001763
Improving clinical cognitive testing
Kirk R. Daffner (2015)
10.1016/S0193-953X(05)70193-3
Cellular mechanisms in the vulnerability to depression and response to antidepressants.
Richard Charles Shelton (2000)
10.1177/0891988707308803
Neurocognitive Costs and Benefits of Psychotropic Medications in Older Adults
John Oliver Brooks (2007)
10.1016/j.ejphar.2014.07.044
Treatment of cognitive dysfunction in major depressive disorder--a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine.
Alan L Pehrson (2015)
10.1097/00004714-200304000-00008
Clinical and neurobiological effects of tianeptine and paroxetine in major depression.
Thomas Nickel (2003)
10.1007/s00213-015-4172-y
Altered cognitive response to serotonin challenge as a candidate endophenotype for obsessive-compulsive disorder
Christine Lochner (2015)
10.1111/j.1600-0447.2008.01285.x
Mediators of the association between depression and role functioning.
Martine Albertine Buist-Bouwman (2008)
10.1017/S0033291713000640
Rapid visual information processing as a cognitive endophenotype of attention deficit hyperactivity disorder.
Susan S F Gau (2014)
10.1037/a0017336
Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis.
Shawn M. McClintock (2010)
10.1016/0028-3932(94)00098-A
Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in man
Adrian M. Owen (1995)
PsychCorp. (2009).Wechsler Memory Scale – Fourth Edition (WMS-IV
Antonio Pearson (2009)
A review of modern anti
E. Biringer (2009)
10.1016/j.biopsych.2006.12.022
A Longitudinal Functional Magnetic Resonance Imaging Study of Verbal Working Memory in Depression After Antidepressant Therapy
Nicholas D. Walsh (2007)
10.1080/026990500413713
Assessing subtle memory impairments in the everyday memory performance of brain injured people: exploring the potential of the extended Rivermead Behavioural Memory Test.
Phillippa Wills (2000)
10.1016/0149-7634(94)00068-C
Effects of antidepressants on cognitive functions: A review
I. Amado-Boccara (1995)
10.1006/cogp.1999.0734
The Unity and Diversity of Executive Functions and Their Contributions to Complex “Frontal Lobe” Tasks: A Latent Variable Analysis
Akira Miyake (2000)
10.1002/hup.725
SSRIs and cognitive performance in a working sample.
Emma Jane Kirsty Wadsworth (2005)
10.1192/bjp.176.5.421
Meta-analysis of randomised controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression.
Per Bech (2000)
Neuropsychological assessment, 5th ed.
Muriel Deutsch Lezak (2012)
Antidepressants and cognitive impairment in the elderly.
Oxman Te (1996)
10.1016/j.psychres.2003.09.003
Cognitive deficits are associated with functional impairment in severely depressed patients
William V McCall (2003)
10.1016/j.jad.2006.01.018
Memory impairment in patients with late-onset major depression: the effect of antidepressant therapy.
Roberto Gallassi (2006)
10.1097/00005053-199712000-00005
Cognitive impairment in the euthymic phase of chronic unipolar depression.
Sergio Paradiso (1997)
10.1016/0165-0327(96)00027-4
Executive dysfunction in depression: the Wisconsin Card Sorting Test.
Shelley Channon (1996)
10.1016/0028-3932(93)90147-R
Investigations of the functional anatomy of attention using the stroop test
Christopher J. Bench (1993)
10.2174/157340009788971137
A Review of Modern Antidepressants Effects on Neurocognitive Function
Eva Biringer (2009)
10.1016/j.biopsych.2005.09.019
Cognitive Function in Late Life Depression: Relationships to Depression Severity, Cerebrovascular Risk Factors and Processing Speed
Yvette I. Sheline (2006)
10.1176/ajp.2007.164.6.900
Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial.
Joel Raskin (2007)
10.1002/hbm.20131
N-back working memory paradigm: a meta-analysis of normative functional neuroimaging studies.
Adrian M. Owen (2005)
The Rivermead Behavioural Memory Test - Extended Version
Barbara Ann Wilson (1999)
10.1016/j.eurpsy.2006.11.004
Computerized assessment of cognition in schizophrenia: promises and pitfalls of CANTAB.
Marie-Noëlle Levaux (2007)
10.1016/j.jad.2009.04.022
A meta-analysis of depression severity and cognitive function.
Lisa McDermott (2009)
10.1080/01688639408402697
Tower of London procedure: a standard method and developmental data.
Robert Owen Krikorian (1994)
10.1016/j.psychres.2005.11.011
Neurocognitive deficits and disability in major depressive disorder
Judith Jaeger (2006)
Antidépresseurs et mémoire. Discussion
Jean Marie Danion (1993)
10.1186/s13643-015-0133-0
Network meta-analysis incorporating randomized controlled trials and non-randomized comparative cohort studies for assessing the safety and effectiveness of medical treatments: challenges and opportunities
Chris Cameron (2015)
10.5860/choice.29-2400
A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary
Otfried Spreen (1991)
10.1002/gps.802
Sertraline treatment of elderly patients with depression and cognitive impairment.
D. P. Devanand (2003)
10.1016/S0361-9230(01)00780-8
The SSRIs drug Fluoxetine, but not the noradrenergic tricyclic drug Desipramine, improves memory performance during acute major depression
Yechiel Levkovitz (2002)
10.1016/j.neuroimage.2004.12.023
Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer
Isabelle Loubinoux (2005)
10.1002/jrsm.12
A basic introduction to fixed-effect and random-effects models for meta-analysis.
Michael Dale Borenstein (2010)
10.1016/j.jad.2005.09.006
Attention and executive functions in remitted major depression patients.
Yvonne Paelecke-Habermann (2005)
10.1517/14728214.2012.660146
Emerging drugs for major depressive disorder
K Ryan Connolly (2012)
10.1016/0028-3932(89)90128-0
Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: Evidence for a specific attentional dysfunction
John J. Downes (1989)
10.1111/j.1600-0447.2000.tb10944.x
Safety and tolerability considerations: tricyclic antidepressants vs. selective serotonin reuptake inhibitors.
Siegfried Peretti (2000)
10.1371/journal.pone.0085035
Using Multiple Types of Studies in Systematic Reviews of Health Care Interventions – A Systematic Review
Frank Peinemann (2013)
10.1016/j.jpsychires.2004.03.003
Executive functions and updating of the contents of working memory in unipolar depression.
P O Harvey (2004)
10.4103/0019-5049.190628
A brief overview of systematic reviews and meta-analyses
Kamath Sriganesh (2016)
10.1016/j.drugalcdep.2011.08.015
Neuropsychological deficits associated with cannabis use in young adults.
Jon Edgar Grant (2012)
10.1002/9780470743386
Introduction to Meta-Analysis
Michael Dale Borenstein (2009)
10.1002/gps.2783
Change in cognitive functioning in depressed older adults following treatment with sertraline or nortriptyline.
Michelle E Culang-Reinlieb (2012)
10.1016/S0887-6177(97)00027-9
A review of the neuropsychological effects of commonly used prescription medications.
Robert Albert Stein (1998)
The effect of duloxetine treatment
M. M. Wohlreich (2012)
Neurocognitive costs and benefits
J. O. Brooks (2007)
10.1016/S2215-0366(16)30067-0
Selection of cognitive tests for trials of therapeutic agents.
John E Harrison (2016)
10.1016/j.ejphar.2014.07.046
Faster, better, stronger: towards new antidepressant therapeutic strategies.
Olivia F. O’Leary (2015)
10.1176/appi.psy.42.1.48
Cognitive improvement with treatment of depression following mild traumatic brain injury.
Jesse R. Fann (2001)
10.1097/PSY.0b013e31825b9855
The effect of duloxetine treatment on cognition in patients with fibromyalgia.
Richard C. Mohs (2012)
10.1093/ijnp/pyv082
The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Joshua D Rosenblat (2015)
10.1097/JCP.0b013e31802e0002
Does fluoxetine have any effect on the cognition of patients with mild cognitive impairment? A double-blind, placebo-controlled, clinical trial.
Arash Mowla (2007)
Conner’s Continuous Performance Test (CPT II) computer programs for Windows: Technical manual and software guide (Ver
C. K. Conners (2000)
Neuropsychological functioning in patients with posttraumatic stress disorder following short-term paroxetine treatment.
Negar Fani (2009)
10.1097/00019442-200409000-00007
Cognitive response to pharmacological treatment for depression in Alzheimer disease: secondary outcomes from the depression in Alzheimer's disease study (DIADS).
Cynthia A Munro (2004)
10.1002/ana.20817
A longitudinal functional magnetic resonance imaging study of language development in children 5 to 11 years old.
Jerzy P. Szaflarski (2006)
Additional dopamine reup
E. F. Vuurman (2002)
10.1007/978-3-319-33967-2_22
Safety and Tolerability
André Russowsky Brunoni (2016)
Mechanism of Actions of Antidepressants: Beyond the Receptors
Ayşegül Yıldız (2002)
10.1016/j.jad.2005.11.003
Pattern of impaired working memory during major depression.
Emma Jane Rose (2006)
Monoamine oxidase: from genes
J. 70193-3. Shih (1999)



This paper is referenced by
10.1080/00207454.2019.1711078
A novel stress re-stress model: Modification of re-stressor cue induces long-lasting post-traumatic stress disorder-like symptoms in rats.
Santosh Kumar Prajapati (2020)
10.1017/S0033291719002228
Telomere length in depression and association with therapeutic response to electroconvulsive therapy and cognitive side-effects.
Karen M Ryan (2019)
10.1016/j.jep.2020.112830
Potential effect of herbal antidepressants on cognitive deficit: Pharmacological activity and possible molecular mechanism.
Jian-Mei Li (2020)
10.1016/j.jad.2019.03.040
Cognitive-functional relationships in major depressive disorder: Crucial data from a Ukrainian open-label study of vortioxetine versus escitalopram.
Oleg A Levada (2019)
10.1007/s11065-019-09415-6
A Guide to Conducting a Meta-Analysis with Non-Independent Effect Sizes
Mike W.-L. Cheung (2019)
10.1097/MD.0000000000014037
FKBP51 is associated with early postoperative cognitive dysfunction in elderly patients undergoing hip fracture surgery
Li-wei Wang (2019)
10.1007/s11065-019-09405-8
Corticosteroids and Cognition: A Meta-Analysis
Catherine E. Prado (2019)
10.1007/s11065-020-09436-6
Depression and Cognitive Control across the Lifespan: a Systematic Review and Meta-Analysis
Vonetta M. Dotson (2020)
10.1016/S2215-0366(19)30291-3
Cognitive function following a major depressive episode: a systematic review and meta-analysis.
Maria Semkovska (2019)
10.1016/j.jad.2018.12.049
Impact of subjective vs. objective remission status on subjective cognitive impairments in depression.
Kyosuke Sawada (2019)
10.1080/23279095.2020.1726919
A pilot study of cognitive remediation in remitted major depressive disorder patients.
Åsa Hammar (2020)
10.1101/2020.02.06.934752
Identifying Nootropic Drug Targets via Large-Scale Cognitive GWAS and Transcriptomics
Max Lam (2020)
10.1016/j.schres.2020.03.008
Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial
Sumudu Rasangi Mallawaarachchi (2020)
10.3389/fneur.2018.00633
Protective Effect of Celecoxib on Early Postoperative Cognitive Dysfunction in Geriatric Patients
Yangzi Zhu (2018)
10.1007/s11065-018-9388-2
Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective
Julia M. Sheffield (2018)
10.1016/j.neurol.2019.01.394
Attention disorders in adults with epilepsy. Determinants and therapeutic strategies.
Hélène Brissart (2019)
10.1016/j.jad.2020.01.068
Effect of repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (MDD) on cognitive control.
Juliana Corlier (2020)
10.1017/S003329171900268X
Childhood maltreatment and cognitive functioning in patients with major depressive disorder: a CAN-BIND-1 report.
Trisha Chakrabarty (2019)
10.3389/fpsyt.2020.00118
Social Cognition and Obsessive-Compulsive Disorder: A Review of Subdomains of Social Functioning
Myrthe Jansen (2020)
10.1186/s12888-019-2197-1
Subjective experiences of neurocognitive functioning in young people with major depression
Catherine Morey-Nase (2019)
10.1007/978-3-030-04266-0_7
Cognitive Dysfunction in the Workplace: Focus on Depression
Raymond W. Lam (2019)
10.31887/DCNS.2019.21.3/trobbins
Pharmacological treatment of cognitive deficits in nondementing mental health disorders

Trevor W. Robbins (2019)
10.1016/j.jad.2018.11.020
Digging deeper in the differential effects of inflammatory and psychosocial stressors in remitted depression: Effects on cognitive functioning.
Peter Niemegeers (2019)
10.1186/s13643-020-01320-x
Cognitive interventions for adults with chronic kidney disease: protocol for a scoping review
Janine F. Farragher (2020)
10.1016/j.neuropharm.2020.108118
Opportunities for multiscale computational modelling of serotonergic drug effects in Alzheimer's disease
Alok Joshi (2020)
Semantic Scholar Logo Some data provided by SemanticScholar